AMAG Pharmaceuticals Just Filed Its Quarterly Report: The components of b...

The components of basic and diluted net loss per share were as follows (in thousands, except per share data):




Three Months Ended March 31,








Net loss








Weighted average common shares outstanding






Net loss per share:






Basic and diluted









The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here.

To receive a free e-mail notification whenever AMAG Pharmaceuticals makes a similar move, sign up!

Other recent filings from the company include the following:

Amag Pharmaceuticals Provides Business Update And 2015 Financial Guidance - Jan. 12, 2015
AMAG: Other Events - Jan. 9, 2015
Major owner of AMAG Pharmaceuticals just disposed of 1,250,000 shares - Jan. 9, 2015
Amag Pharmaceuticals And Takeda Announce Mutual Termination Of Agreement To License, - Dec. 29, 2014

   Auto Refresh